In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts.
about
Melaleuca alternifolia (Tea Tree) oil: a review of antimicrobial and other medicinal propertiesEffects of Melaleuca alternifolia (tea tree) essential oil and the major monoterpene component terpinen-4-ol on the development of single- and multistep antibiotic resistance and antimicrobial susceptibilityIn vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida speciesAntifungal Properties of Chenopodium ambrosioides Essential Oil Against Candida Species.Liquid and vapour-phase antifungal activities of selected essential oils against Candida albicans: microscopic observations and chemical characterization of Cymbopogon citratus.Beneficial effect of Mentha suaveolens essential oil in the treatment of vaginal candidiasis assessed by real-time monitoring of infection.Plant-derived antimicrobial compounds: alternatives to antibiotics.In vitro antifungal activity of epigallocatechin 3-O-gallate against clinical isolates of dermatophytes.In Vitro and In Vivo Activities of Essential Oil from the Seed of Anethum graveolens L. against Candida spp.In Vitro Activity of Tea Tree Oil Vaginal Suppositories against Candida spp. and Probiotic Vaginal Microbiota.Plants of the Melaleuca Genus as Antimicrobial Agents: From Farm to Pharmacy.Antifungal effect of plant extract and essential oil.Antifungal, cytotoxic, and immunomodulatory properties of tea tree oil and its derivative components: potential role in management of oral candidosis in cancer patients.Commercial Essential Oils as Potential Antimicrobials to Treat Skin Diseases.Comparison of the cidal activity of tea tree oil and terpinen-4-ol against clinical bacterial skin isolates and human fibroblast cells.The influence of tea tree oil (Melaleuca alternifolia) on fluconazole activity against fluconazole-resistant Candida albicans strains.Anticandidal efficacy of cinnamon oil against planktonic and biofilm cultures of Candida parapsilosis and Candida orthopsilosis.Antifungal activity of essential oils and their synergy with fluconazole against drug-resistant strains of Aspergillus fumigatus and Trichophyton rubrum.Evaluation of anti-Candida potential of geranium oil constituents against clinical isolates of Candida albicans differentially sensitive to fluconazole: inhibition of growth, dimorphism and sensitization.Antifungal activity of the naphthoquinone beta-lapachone against disseminated infection with Cryptococcus neoformans var. neoformans in dexamethasone-immunosuppressed Swiss mice.In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp.Candida albicans adhesion to human epithelial cells and polystyrene and formation of biofilm is reduced by sub-inhibitory Melaleuca alternifolia (tea tree) essential oil.
P2860
Q24537344-5E4E53A5-EB6B-4FDC-A662-0A0164467B1DQ24604284-8EF78682-70B8-49EB-9CA0-433A15C96E9FQ33262661-F8A670FE-AB76-4B8E-878D-3A3F96F2319FQ33664721-BB47F25F-8674-4F47-85E5-0C0FCCC52011Q33743638-A45403C2-00B3-4D61-B564-B811EE18E7AAQ33830972-19433275-4CB7-44C8-95BD-5616A83FB134Q34295343-2FC8C702-BA9D-4519-B865-7F06F84EE96FQ35003423-171295E5-5B1E-4A0A-8E3D-1C9623BACB49Q35056809-2F241A87-2614-49FB-9AC7-D07EEF5B79B0Q35734134-C220B1A3-BC51-434A-B15C-F7E91950C3CFQ38637737-B4DA11D1-8850-463E-9D3C-32296710C3E0Q38945120-74AFD5AF-8E9F-468D-B99C-826C7E0C0DBFQ39327502-599687D3-C2F7-4B6A-B9D0-936110E55BA7Q39331661-9870BA10-2520-4BE3-A0A2-3E82D99A7D83Q40009140-A9145FE8-C826-4934-8297-B9BD68564F6CQ41460980-AFBC9181-B227-4DCE-9BF9-4E961DA2B29AQ42730616-3390420F-119E-4C32-A413-D5F15CDA3358Q42749863-09162DB0-E386-43F0-AAB1-5E90CB9AAF42Q43118762-AF57342F-B850-42E3-93CB-E05E1ABA233BQ43140020-03A27CA0-46AA-4C2C-9A94-CF780108CC3FQ46255280-D43E965A-3865-4BAB-9E67-DE31264E4FABQ47761804-FAEE75DE-6AF5-4761-8B1B-2E03FEC5D0C1
P2860
In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
In vitro and in vivo activity ...... stant human pathogenic yeasts.
@ast
In vitro and in vivo activity ...... stant human pathogenic yeasts.
@en
In vitro and in vivo activity ...... stant human pathogenic yeasts.
@nl
type
label
In vitro and in vivo activity ...... stant human pathogenic yeasts.
@ast
In vitro and in vivo activity ...... stant human pathogenic yeasts.
@en
In vitro and in vivo activity ...... stant human pathogenic yeasts.
@nl
prefLabel
In vitro and in vivo activity ...... stant human pathogenic yeasts.
@ast
In vitro and in vivo activity ...... stant human pathogenic yeasts.
@en
In vitro and in vivo activity ...... stant human pathogenic yeasts.
@nl
P2093
P356
P1476
In vitro and in vivo activity ...... istant human pathogenic yeasts
@en
P2093
Antonietta Girolamo
Antonio Cassone
Flavia De Bernardis
Giuseppe Salvatore
P304
P356
10.1093/JAC/DKG202
P407
P577
2003-03-28T00:00:00Z